Cocrystal Pharma Q2 EPS $(0.04) Up From $(0.07) YoY

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losses of $(0.07) per share from the same period last year.

byBill Haddad

August 16, 2021

1 minute read

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losses of $(0.07) per share from the same period last year.

Funko Consolidates Its US Distribution Facility To Arizona

By Shivani Kumaresan

Today, 3:05 AM

Pop culture lifestyle brand Funko Inc (NASDAQ:FNKO) has relocated its main U.S. distribution facility from several distribution centers in Washington to one…

FNKO

BMO Capital Maintains Market Perform on Monster Beverage, Lowers Price Target to $90

By Benzinga Newsdesk

Today, 3:05 AM

BMO Capital analyst Andrew Strelzik maintains Monster Beverage (NASDAQ:MNST) with a Market Perform and lowers the price target from $92 to $90.

MNST

Kandi Technologies Group Q2 EPS $0.54 Beats $(0.18) Estimate, Sales $29.90M Beat $20.80M Estimate

By Bill Haddad

Today, 3:05 AM

Kandi Technologies Group (NASDAQ:KNDI) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $(0.18) by 400 percent. This is a 1000 percent increase over losses of $(0.06) per share

KNDI

American Water Works Co Q3 EPS $1.63 Beats $1.52 Estimate, Sales $1.08B Beat $1.08B Estimate

By Benzinga Newsdesk

Today, 3:05 AM

American Water Works Co (NYSE:AWK) reported quarterly earnings of $1.63 per share which beat the analyst consensus estimate of $1.52 by 7.24 percent. This is a 6.54 percent increase over earnings of $1.53 per share from

AWK

Cocrystal Pharma Q2 EPS $(0.04) Up From $(0.07) YoY

Related Posts

Funko Consolidates Its US Distribution Facility To Arizona

BMO Capital Maintains Market Perform on Monster Beverage, Lowers Price Target to $90

Kandi Technologies Group Q2 EPS $0.54 Beats $(0.18) Estimate, Sales $29.90M Beat $20.80M Estimate

American Water Works Co Q3 EPS $1.63 Beats $1.52 Estimate, Sales $1.08B Beat $1.08B Estimate